reference/32344748

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32344748

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Journal Article\|Multicenter Study\|Research Support, Non-U.S. Gov't
endingPage	4261
issn	1557-3265 1078-0432
issueIdentifier	16
pageRange	4251-4261
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	4251
bibliographicCitation	Zimmer L, Barlesi F, Martinez-Garcia M, Dieras V, Schellens JH, Spano JP, Middleton MR, Calvo E, Paz-Ares L, Larkin J, Pacey S, Venturi M, Kraeber-Bodéré F, Tessier JJ, Eberhardt WE, Paques M, Guarin E, Meresse V, Soria JC. Phase I expansion and pharmacodynamic study of the oral MEK inhibitor RO4987655 (CH4987655) in selected patients with advanced cancer with RAS-RAF mutations. Clin Cancer Res. 2014 Aug 15;20(16):4251–61. doi: 10.1158/1078-0432.ccr-14-0341. PMID: 24947927.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d4e5d20baf75aaf5280cb8f08814911 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_914facc05e72563a6685aacaf7197f99 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0be8c26c52dcf3c18d272de2560c2810 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a8fed7f94ebe8eb1b0bf944932d2ed7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_099dab708df421d7dab9a9ad5b5d683c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8b73d7b4d35fa0a2cfac7b1bd1e67cd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0b2d916af9d9aab1ccddc3b147e3e54 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9102-9196 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5569-9523 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_00359f4dea2659383ce72344ae64ce6d http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4921-829X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af05d651460bc947cb9cad26714bb21b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_36b5edaa83e5476e2b872a3fc6ae82fb http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4284-3586 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6a76026147aebf2a1ede92f66f4a1ee http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23c1276a54b68190941d93ad362a11f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eeaed9599de5e5622b3419feda5bef58 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4307b79a61b6adb83cff0822bb9c486d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed72b827f73b2543fd8e4218a620f05f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3643a46fb11a634bff3075f02db59722 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3417-0759 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_230039b6d6f1a647c7434b3e26dbe028 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6078a59a75fd45cd267f16663a844609 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_825588abc480fb5fea30e97f215399f2
date	2014-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1158/1078-0432.ccr-14-0341 https://pubmed.ncbi.nlm.nih.gov/24947927
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794 https://portal.issn.org/resource/ISSN/1078-0432 https://portal.issn.org/resource/ISSN/1557-3265
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Phase I Expansion and Pharmacodynamic Study of the Oral MEK Inhibitor RO4987655 (CH4987655) in Selected Patients with Advanced Cancer with RAS–RAF Mutations
discusses	http://id.nlm.nih.gov/mesh/M0027924 http://id.nlm.nih.gov/mesh/M0452142 http://id.nlm.nih.gov/mesh/M0328033 http://id.nlm.nih.gov/mesh/M0558782 http://id.nlm.nih.gov/mesh/M0029573 http://id.nlm.nih.gov/mesh/M0543055 http://id.nlm.nih.gov/mesh/M0543042 http://id.nlm.nih.gov/mesh/M0024891 http://id.nlm.nih.gov/mesh/M0015639 http://id.nlm.nih.gov/mesh/M0465491 http://id.nlm.nih.gov/mesh/M0017909 http://id.nlm.nih.gov/mesh/M0301174 http://id.nlm.nih.gov/mesh/M0002327
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D010078Q000627 http://id.nlm.nih.gov/mesh/D020930Q000037 http://id.nlm.nih.gov/mesh/D048493Q000235 http://id.nlm.nih.gov/mesh/D009154Q000235 http://id.nlm.nih.gov/mesh/D018631Q000235 http://id.nlm.nih.gov/mesh/D009369Q000188 http://id.nlm.nih.gov/mesh/D001549Q000627 http://id.nlm.nih.gov/mesh/D011518Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D010078Q000493 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D004252 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D018579 http://id.nlm.nih.gov/mesh/D016283 http://id.nlm.nih.gov/mesh/D001549Q000493 http://id.nlm.nih.gov/mesh/D014018 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D058534 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D019869Q000235 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D009369Q000235 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D009369Q000473 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e1afa113b0d884f36154ce9339375de8 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID170049 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c7be83279551b50c0e81dc2dbfe3c5d8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7660 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_606d6234a2cf2e2d52b0ade7ed869ca5 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8448 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11548630 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7811 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6569 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7429 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1c50845b337a3c11fa194521642a3ec8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID673 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3845 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID363894204

Total number of triples: 103.